1. Home
  2. JAGX vs DRCT Comparison

JAGX vs DRCT Comparison

Compare JAGX & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$2.81

Market Cap

2.2M

Sector

Health Care

ML Signal

HOLD

Logo Direct Digital Holdings Inc.

DRCT

Direct Digital Holdings Inc.

HOLD

Current Price

$2.85

Market Cap

1.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAGX
DRCT
Founded
2013
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
1.9M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
JAGX
DRCT
Price
$2.81
$2.85
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$60.00
$32.00
AVG Volume (30 Days)
62.4K
28.7K
Earning Date
04-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
82.42
N/A
EPS
N/A
N/A
Revenue
$11,511,000.00
$34,694,000.00
Revenue This Year
$61.58
$5.42
Revenue Next Year
N/A
$9.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.04
52 Week High
$8.00
$7.21

Technical Indicators

Market Signals
Indicator
JAGX
DRCT
Relative Strength Index (RSI) 50.55 48.92
Support Level $1.76 $2.73
Resistance Level $4.13 $3.04
Average True Range (ATR) 0.27 0.19
MACD 0.03 -0.01
Stochastic Oscillator 72.63 57.64

Price Performance

Historical Comparison
JAGX
DRCT

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

Share on Social Networks: